Research Overview

John Triedman's research is aimed at improving techniques to diagnose and treat cardiac arrhythmias--particularly atrial re-entrant tachycardia. He also performs numerical analysis of cardiovascular electrophysiology.

His current work is focused on developing techniques for the visualizing the electrophysiological properties of the right atrium and on developing therapies to prevent and treat postoperative arrhythmia.

Research Background

John Triedman received his MD from Harvard Medical School. He completed an internship, residency, and fellowship at Boston Children's Hospital.

 

Education

Undergraduate School

Harvard College
1980 Cambridge MA

Medical School

Harvard Medical School
1985 Boston MA

Internship

Boston Children's Hospital
1986 Boston MA

Residency

Boston Children's Hospital
1988 Boston MA

Fellowship

Cardiac Electrophysiology Boston Children's Hospital
1991 Boston MA

Publications

  1. Electrocardiogram-based deep learning to predict mortality in paediatric and adult congenital heart disease. Eur Heart J. 2025 Mar 03; 46(9):856-868. View Abstract
  2. Artificial Intelligence-Enabled Electrocardiogram Predicts Sudden Cardiac Death in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2025 Mar; 11(3):593-595. View Abstract
  3. Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19; 84(21):2102-2112. View Abstract
  4. Electrocardiogram-Based Deep Learning to Predict Mortality in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2024 Dec; 10(12):2600-2612. View Abstract
  5. Efficacy and safety of early postoperative ablation in patients with congenital heart disease. Heart Rhythm. 2024 Sep 06. View Abstract
  6. Deep Learning-Based Electrocardiogram Analysis Predicts Biventricular Dysfunction and Dilation in Congenital Heart Disease. J Am Coll Cardiol. 2024 Aug 27; 84(9):815-828. View Abstract
  7. Pediatric Electrocardiogram-Based Deep Learning to Predict Secundum Atrial Septal Defects. Pediatr Cardiol. 2024 Jul 02. View Abstract
  8. Comparative utility of omnipolar and bipolar electroanatomic mapping methods to detect and localize dual nodal substrate in patients with atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol. 2024 Oct; 67(7):1579-1591. View Abstract
  9. Limited Relationship Between Echocardiographic Measures and Electrocardiographic Markers of Left Ventricular Size in Healthy Children. Pediatr Cardiol. 2024 Jun; 45(5):1055-1063. View Abstract
  10. Pediatric ECG-Based Deep Learning to Predict Left Ventricular Dysfunction and Remodeling. Circulation. 2024 03 19; 149(12):917-931. View Abstract
  11. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. J Cardiovasc Electrophysiol. 2023 12; 34(12):2545-2551. View Abstract
  12. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part I: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 09 12; 82(11):1108-1120. View Abstract
  13. Ventricular Arrhythmias in Adults With Congenital Heart Disease, Part II: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023 09 12; 82(11):1121-1130. View Abstract
  14. Clinical implications of a unique delta wave pattern in patients with left-sided Wolff-Parkinson-White. Europace. 2023 05 19; 25(5). View Abstract
  15. Insight into the Role of the Child Opportunity Index on Surgical Outcomes in Congenital Heart Disease. J Pediatr. 2023 08; 259:113464. View Abstract
  16. Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease. Heart Rhythm. 2023 07; 20(7):1011-1017. View Abstract
  17. Conduction mapping during complex congenital heart surgery: Creating a predictive model of conduction anatomy. J Thorac Cardiovasc Surg. 2023 05; 165(5):1618-1628. View Abstract
  18. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Ann Pediatr Cardiol. 2022 May-Jun; 15(3):323-346. View Abstract
  19. Pediatric Electrophysiology Device Needs: A Survey from the Pediatric and Congenital Electrophysiology Society Taskforce on Pediatric-Specific Devices. J Am Heart Assoc. 2022 11 15; 11(22):e026904. View Abstract
  20. Radiofrequency Catheter Ablation for Pediatric Atrioventricular Nodal Reentrant Tachycardia: Impact of Age on Procedural Methods and Durable Success. J Am Heart Assoc. 2022 06 21; 11(12):e022799. View Abstract
  21. Intraoperative conduction mapping in complex congenital heart surgery. JTCVS Tech. 2022 Apr; 12:159-163. View Abstract
  22. Lead Extraction at a Pediatric/Congenital Heart Disease Center: The Importance of Patient Age at Implant. JACC Clin Electrophysiol. 2022 03; 8(3):343-353. View Abstract
  23. Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices. Pediatr Cardiol. 2022 Apr; 43(4):784-789. View Abstract
  24. Pediatric T-wave memory after accessory pathway ablation in Wolff-Parkinson-White syndrome. Heart Rhythm. 2022 03; 19(3):459-465. View Abstract
  25. The Evolution of a Gold Standard in Cardiac Electrophysiology. JACC Clin Electrophysiol. 2021 09; 7(9):1118-1119. View Abstract
  26. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Cardiol Young. 2021 Nov; 31(11):1738-1769. View Abstract
  27. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary. Cardiol Young. 2021 Nov; 31(11):1717-1737. View Abstract
  28. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). JACC Clin Electrophysiol. 2021 11; 7(11):1437-1472. View Abstract
  29. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary. Heart Rhythm. 2021 11; 18(11):1925-1950. View Abstract
  30. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. Heart Rhythm. 2021 11; 18(11):1888-1924. View Abstract
  31. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Indian Pacing Electrophysiol J. 2021 Nov-Dec; 21(6):367-393. View Abstract
  32. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Executive summary. Indian Pacing Electrophysiol J. 2021 Nov-Dec; 21(6):349-366. View Abstract
  33. Accessory pathway ablation in Ebstein anomaly: A challenging substrate. Heart Rhythm. 2021 11; 18(11):1844-1851. View Abstract
  34. Preventing Arrhythmic Death in Patients With Tetralogy of Fallot: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 02 16; 77(6):761-771. View Abstract
  35. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2020 12; 31(12):3243-3250. View Abstract
  36. Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008848. View Abstract
  37. Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Pacing Clin Electrophysiol. 2020 09; 43(9):901-907. View Abstract
  38. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population. Heart Rhythm. 2020 06; 17(6):984-990. View Abstract
  39. Outcomes of catheter ablation of anteroseptal and midseptal accessory pathways in pediatric patients. Heart Rhythm. 2020 05; 17(5 Pt A):759-767. View Abstract
  40. Arrhythmia Mechanisms and Outcomes of Ablation in Pediatric Patients With Congenital Heart Disease. Circ Arrhythm Electrophysiol. 2019 11; 12(11):e007663. View Abstract
  41. The Real-World Utility of the LINQ Implantable Loop Recorder in Pediatric and Adult Congenital Heart Patients. JACC Clin Electrophysiol. 2019 02; 5(2):245-251. View Abstract
  42. Pediatric and congenital electrophysiology society initiative on device needs in pediatric electrophysiology. Heart Rhythm. 2019 04; 16(4):e39-e46. View Abstract
  43. Hospital Costs Related to Early Extubation After Infant Cardiac Surgery. Ann Thorac Surg. 2019 05; 107(5):1421-1426. View Abstract
  44. Measuring defibrillator surface potentials: The validation of a predictive defibrillation computer model. Comput Biol Med. 2018 11 01; 102:402-410. View Abstract
  45. Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing? JACC Clin Electrophysiol. 2018 10; 4(10):1289-1297. View Abstract
  46. Evaluation of left ventricular false tendons in children with idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol. 2018 09; 41(9):1143-1149. View Abstract
  47. Utility of incomplete right bundle branch block as an isolated ECG finding in children undergoing initial cardiac evaluation. Congenit Heart Dis. 2018 May; 13(3):419-427. View Abstract
  48. Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures. Congenit Heart Dis. 2018 Mar; 13(2):222-225. View Abstract
  49. Cardiac Events During Competitive, Recreational, and Daily Activities in Children and Adolescents With Long QT Syndrome. J Am Heart Assoc. 2017 Sep 21; 6(9). View Abstract
  50. Epicardial ablation of tachyarrhythmia in children: Experience at two academic centers. Pacing Clin Electrophysiol. 2017 Sep; 40(9):1017-1026. View Abstract
  51. Moving the Goalposts: Prevention of Atrial Arrhythmias After Congenital Heart Surgery. Circ Arrhythm Electrophysiol. 2016 12; 9(12). View Abstract
  52. Keeping time in the chest. Heart Rhythm. 2017 02; 14(2):300-301. View Abstract
  53. Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network. J Thorac Cardiovasc Surg. 2017 03; 153(3):638-645.e2. View Abstract
  54. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart Rhythm. 2017 01; 14(1):e41-e44. View Abstract
  55. Trends in Congenital Heart Disease: The Next Decade. Circulation. 2016 Jun 21; 133(25):2716-33. View Abstract
  56. Pediatric & Congenital Electrophysiology Society: building an international paediatric electrophysiology organisation. Heart Rhythm. 2016 05; 13(5):1006-1009. View Abstract
  57. Pediatric & Congenital Electrophysiology Society: building an international paediatric electrophysiology organisation. Cardiol Young. 2016 Aug; 26(6):1039-43. View Abstract
  58. Sudden Cardiac Death in the Young. Circulation. 2016 Mar 08; 133(10):1006-26. View Abstract
  59. Catheter ablation for atrioventricular nodal reentrant tachycardia in patients with congenital heart disease. Heart Rhythm. 2016 06; 13(6):1228-37. View Abstract
  60. Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign? Int J Cardiol. 2016 Mar 01; 206:158-63. View Abstract
  61. Arrhythmias in Adult Congenital Heart Disease: Diagnosis and Management. Cardiol Clin. 2015 Nov; 33(4):571-88, viii. View Abstract
  62. Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects. Circ Arrhythm Electrophysiol. 2015 Oct; 8(5):1065-72. View Abstract
  63. Reply to the Editor--Detection of long QT syndrome in the community. Heart Rhythm. 2015 Jul; 12(7):e67-8. View Abstract
  64. A method to account for variation in congenital heart surgery charges. Ann Thorac Surg. 2015 Mar; 99(3):939-46. View Abstract
  65. Mechanism and ablation of arrhythmia following total cavopulmonary connection. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):318-25. View Abstract
  66. Neonatal ECG screening: opinions and facts. Heart Rhythm. 2015 Mar; 12(3):610-611. View Abstract
  67. My approach to Wolff-Parkinson-White syndrome. Trends Cardiovasc Med. 2015 Apr; 25(3):261-2. View Abstract
  68. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014 Oct; 30(10):e1-e63. View Abstract
  69. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1057-63. View Abstract
  70. Rationale and objectives for ECG screening in infancy. Heart Rhythm. 2014 Dec; 11(12):2316-21. View Abstract
  71. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014 09; 16(9):1257-83. View Abstract
  72. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014 Oct; 11(10):e166-96. View Abstract
  73. Searching for a Rosetta Stone: genetic data and clinical patient management. Heart Rhythm. 2014 Oct; 11(10):1714-5. View Abstract
  74. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e81-e101. View Abstract
  75. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e102-65. View Abstract
  76. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol. 2014 Jul 01; 307(1):H110-7. View Abstract
  77. Guidelines for management of asymptomatic ventricular pre-excitation: brave new world or Pandora's box? Circ Arrhythm Electrophysiol. 2014 Apr; 7(2):187-9. View Abstract
  78. Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm. 2014 Feb; 11(2):182-6. View Abstract
  79. Incidence of and risk factors for catheterization-induced complete heart block in the pediatric cardiac catheterization laboratory. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):127-33. View Abstract
  80. Post-mortem genetic testing in a family with long-QT syndrome and hypertrophic cardiomyopathy. Cardiovasc Pathol. 2014 Mar-Apr; 23(2):107-9. View Abstract
  81. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythm Electrophysiol. 2013 Oct; 6(5):1032-40. View Abstract
  82. Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations. J Am Heart Assoc. 2013 Sep 19; 2(5):e000325. View Abstract
  83. The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block. Ann Thorac Surg. 2013 Sep; 96(3):904-9. View Abstract
  84. The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. 2014 Feb; 16(2):277-83. View Abstract
  85. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int J Cardiol. 2013 Oct 09; 168(4):3940-3. View Abstract
  86. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol. 2013 Sep; 36(9):1117-22. View Abstract
  87. COMPASS: a novel risk-adjustment model for catheter ablation in pediatric and congenital heart disease patients. Congenit Heart Dis. 2013 Sep-Oct; 8(5):393-405. View Abstract
  88. Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. J Cardiovasc Electrophysiol. 2013 Jun; 24(6):640-8. View Abstract
  89. Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Pacing Clin Electrophysiol. 2013 May; 36(5):607-11. View Abstract
  90. Multiple accessory pathways in the young: the impact of structural heart disease. Am Heart J. 2013 Jan; 165(1):87-92. View Abstract
  91. Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients. Pacing Clin Electrophysiol. 2012 Dec; 35(12):1487-93. View Abstract
  92. If the shoe fits: antitachycardia pacing in children and patients with congenital heart disease. Heart Rhythm. 2012 Nov; 9(11):1835-6. View Abstract
  93. Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circ Heart Fail. 2012 Jul 01; 5(4):462-6. View Abstract
  94. PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm. 2012 Jun; 9(6):1006-24. View Abstract
  95. Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation. 2012 May 29; 125(21):2621-9. View Abstract
  96. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics. 2012 Apr; 129(4):e999-1010. View Abstract
  97. Follow-up of a modified Fontan randomized trial for intraatrial reentrant tachycardia prophylaxis. Congenit Heart Dis. 2012 May-Jun; 7(3):219-25. View Abstract
  98. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol. 2011 Oct 25; 58(18):1903-9. View Abstract
  99. The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol. 2011 Sep; 22(9):1013-7. View Abstract
  100. Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Am J Cardiol. 2011 May 15; 107(10):1535-40. View Abstract
  101. Nonfluoroscopic imaging systems reduce radiation exposure in children undergoing ablation of supraventricular tachycardia. Heart Rhythm. 2011 Apr; 8(4):519-25. View Abstract
  102. Development of an ovine model of pediatric complete heart block. J Surg Res. 2011 Apr; 166(2):e103-8. View Abstract
  103. The risk of ionizing radiation in electrophysiology studies and ablations. Pacing Clin Electrophysiol. 2011 Mar; 34(3):261-3. View Abstract
  104. Children are not just small adults. Heart Rhythm. 2011 Jan; 8(1):29-30. View Abstract
  105. Lead extraction in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol. 2010 Oct; 3(5):437-44. View Abstract
  106. Epicardial left atrial appendage and biatrial appendage accessory pathways. Heart Rhythm. 2010 Dec; 7(12):1740-5. View Abstract
  107. Needle in a haystack: modeling the incidence of sudden cardiac arrest in healthy children. Circulation. 2010 Mar 23; 121(11):1283-5. View Abstract
  108. Finite element modeling of subcutaneous implantable defibrillator electrodes in an adult torso. Heart Rhythm. 2010 May; 7(5):692-8. View Abstract
  109. Atrial remodeling after the Fontan operation. Am J Cardiol. 2009 Dec 15; 104(12):1737-42. View Abstract
  110. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm. 2010; 7(2):193-8. View Abstract
  111. Management of asymptomatic Wolff-Parkinson-White syndrome. Heart. 2009 Oct; 95(19):1628-34. View Abstract
  112. The Meaning of Lethal Events in Infants With Long QT Syndrome. J Am Coll Cardiol. 2009 Aug 25; 54(9):838-9. View Abstract
  113. Brugada and short QT syndromes. Pacing Clin Electrophysiol. 2009 Jul; 32 Suppl 2:S58-62. View Abstract
  114. Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol. 2009 Jun; 32(6):779-85. View Abstract
  115. Procedural innovation and ablation of pediatric SVT. J Cardiovasc Electrophysiol. 2009 Jun; 20(6):643-4. View Abstract
  116. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease. Circ Arrhythm Electrophysiol. 2008 Oct; 1(4):307-16; discussion 316. View Abstract
  117. Predictive modeling of defibrillation using hexahedral and tetrahedral finite element models: recent advances. J Electrocardiol. 2008 Nov-Dec; 41(6):483-6. View Abstract
  118. Ascending aortic dilation in patients with congenital complete heart block. Heart Rhythm. 2008 Dec; 5(12):1704-8. View Abstract
  119. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009 Jan; 20(1):58-65. View Abstract
  120. Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Int J Cardiol. 2009 Nov 12; 137(3):260-6. View Abstract
  121. Atrioventricular nodal reentrant tachycardia with 2:1 block in pediatric patients. Heart Rhythm. 2008 Oct; 5(10):1391-5. View Abstract
  122. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008 Apr 29; 51(17):1685-91. View Abstract
  123. Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function. Heart Rhythm. 2008 Apr; 5(4):545-50. View Abstract
  124. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008 Mar; 31(3):338-43. View Abstract
  125. Hypotension from epinephrine in a food-allergic patient with long QT syndrome. Ann Allergy Asthma Immunol. 2008 Feb; 100(2):174-5. View Abstract
  126. A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm. 2008 Apr; 5(4):565-72. View Abstract
  127. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008 Jan 01; 117(1):85-92. View Abstract
  128. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2008 Jan; 21(1):65-8. View Abstract
  129. Imaging artifacts of medical instruments in ultrasound-guided interventions. J Ultrasound Med. 2007 Oct; 26(10):1303-22. View Abstract
  130. Atypical atrial tachycardias in patients with congenital heart disease. Heart Rhythm. 2008 Feb; 5(2):315-7. View Abstract
  131. Successful cryoablation of ventricular tachycardia arising from the proximal right bundle branch in a child. Heart Rhythm. 2008 Jan; 5(1):142-4. View Abstract
  132. Evaluation of different meshing algorithms in the computation of defibrillation thresholds in children. Annu Int Conf IEEE Eng Med Biol Soc. 2007; 2007:1422-5. View Abstract
  133. Cost effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J. 2007 Jan; 28(1):137; author reply137-9. View Abstract
  134. Cardiac conduction through engineered tissue. Am J Pathol. 2006 Jul; 169(1):72-85. View Abstract
  135. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol. 2006 Jul; 17(7):754-9. View Abstract
  136. Producing diffuse ultrasound reflections from medical instruments using a quadratic residue diffuser. Ultrasound Med Biol. 2006 May; 32(5):721-7. View Abstract
  137. Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease. J Cardiovasc Electrophysiol. 2006 Apr; 17(4):359-65. View Abstract
  138. Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm. 2006 Mar; 3(3):253-8. View Abstract
  139. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006 Jan; 17(1):41-6. View Abstract
  140. Image based modeling of defibrillation in children. Conf Proc IEEE Eng Med Biol Soc. 2006; 2006:2564-7. View Abstract
  141. Virtual reality in interventional electrophysiology. Circulation. 2005 Dec 13; 112(24):3677-9. View Abstract
  142. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 2005 Nov 29; 112(22):3470-7. View Abstract
  143. Modification of the slow pathway in atrioventricular nodal reentrant tachycardia: no pain, no gain. Heart Rhythm. 2005 Nov; 2(11):1186-7. View Abstract
  144. Three-dimensional echo-guided beating heart surgery without cardiopulmonary bypass: atrial septal defect closure in a swine model. J Thorac Cardiovasc Surg. 2005 Nov; 130(5):1348-57. View Abstract
  145. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005 Oct; 14(1):27-36. View Abstract
  146. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm. 2005 Jul; 2(7):700-5. View Abstract
  147. Inability to cannulate the coronary sinus in patients with supraventricular arrhythmias: congenital and acquired coronary sinus atresia. J Interv Card Electrophysiol. 2005 Mar; 12(2):123-7. View Abstract
  148. Risk stratification for prophylactic ablation in asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med. 2005 Jan 06; 352(1):92-3; author reply 92-3. View Abstract
  149. Identification of cardiac rhythm features by mathematical analysis of vector fields. IEEE Trans Biomed Eng. 2005 Jan; 52(1):19-29. View Abstract
  150. Three-dimensional echocardiography-guided beating-heart surgery without cardiopulmonary bypass: a feasibility study. J Thorac Cardiovasc Surg. 2004 Oct; 128(4):579-87. View Abstract
  151. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004 Sep; 1(3):301-8. View Abstract
  152. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):150-9. View Abstract
  153. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):168-73. View Abstract
  154. Three-dimensional echocardiography-guided atrial septectomy: an experimental study. J Thorac Cardiovasc Surg. 2004 Jul; 128(1):53-9. View Abstract
  155. Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am J Cardiol. 2004 Jun 01; 93(11):1449-52, A12. View Abstract
  156. Ablation of atrioventricular nodal reentrant tachycardia in tricuspid atresia. J Cardiovasc Electrophysiol. 2004 Jun; 15(6):719-22. View Abstract
  157. Comparative psychometric analysis of vector and isochrone cardiac activation maps. IEEE Trans Biomed Eng. 2004 May; 51(5):847-55. View Abstract
  158. So far, so good... J Cardiovasc Electrophysiol. 2004 Mar; 15(3):284-5. View Abstract
  159. Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg. 2004 Mar; 127(3):721-9. View Abstract
  160. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004 Jan; 15(1):72-6. View Abstract
  161. Radiofrequency catheter ablation of septal accessory pathways in the pediatric age group. Am J Cardiol. 2003 Oct 15; 92(8):947-50. View Abstract
  162. Estimation of cardiac conduction velocities using small data sets. Ann Biomed Eng. 2003 Mar; 31(3):250-61. View Abstract
  163. Pericaval and periannular intra-atrial reentrant tachycardias in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):119-25. View Abstract
  164. Application of robotics in congenital cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2003; 6:72-83. View Abstract
  165. Estimation of entrainment response using electrograms from remote sites: validation in animal and computer models of reentrant tachycardia. J Cardiovasc Electrophysiol. 2003 Jan; 14(1):52-61. View Abstract
  166. Heart rate control and mechanical cardiopulmonary coupling to assess central volume: a systems analysis. Am J Physiol Regul Integr Comp Physiol. 2002 Nov; 283(5):R1210-20. View Abstract
  167. Circadian and seasonal variation of malignant arrhythmias in a pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2002 Oct; 13(10):1009-14. View Abstract
  168. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002 Aug 01; 90(3):338-40. View Abstract
  169. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002 Jun 05; 39(11):1827-35. View Abstract
  170. Arrhythmias in adults with congenital heart disease. Heart. 2002 Apr; 87(4):383-9. View Abstract
  171. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol. 2001 Dec; 24(12):1789-94. View Abstract
  172. Postoperative ectopic atrial tachycardia in children with congenital heart disease. Am J Cardiol. 2001 Nov 15; 88(10):1169-72. View Abstract
  173. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001 Oct; 12(10):1097-101. View Abstract
  174. Induction of atrial tachycardia and fibrillation in the mouse heart. Cardiovasc Res. 2001 Jun; 50(3):463-73. View Abstract
  175. Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease. J Cardiovasc Electrophysiol. 2001 Jun; 12(6):671-9. View Abstract
  176. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001 May; 37(6):1665-76. View Abstract
  177. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001 Apr 24; 103(16):2060-5. View Abstract
  178. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):28-41. View Abstract
  179. Electroanatomic characterization of conduction barriers in sinus/atrially paced rhythm and association with intra-atrial reentrant tachycardia circuits following congenital heart disease surgery. J Cardiovasc Electrophysiol. 2001 Jan; 12(1):17-25. View Abstract
  180. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000 Nov 01; 86(9):969-74. View Abstract
  181. Estimation of atrial response to entrainment pacing using electrograms recorded from remote sites. J Cardiovasc Electrophysiol. 2000 Nov; 11(11):1215-22. View Abstract
  182. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol. 2000 Aug; 279(2):H733-40. View Abstract
  183. Focal ablation of chaotic atrial rhythm in an infant with cardiomyopathy. J Cardiovasc Electrophysiol. 2000 May; 11(5):577-81. View Abstract
  184. Sudden death in patients after transcatheter device implantation for congenital heart disease. Am J Cardiol. 2000 Apr 15; 85(8):992-5. View Abstract
  185. Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. J Pediatr. 2000 Apr; 136(4):481-9. View Abstract
  186. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999 Aug; 10(8):1033-44. View Abstract
  187. Long-term performance of bipolar epicardial atrial pacing using an active fixation bipolar endocardial lead. Pacing Clin Electrophysiol. 1998 May; 21(5):1098-104. View Abstract
  188. Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. J Pediatr. 1997 Dec; 131(6):878-87. View Abstract
  189. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997 Oct; 30(4):1032-8. View Abstract
  190. Model dependency of multivariate autoregressive spectral analysis. IEEE Eng Med Biol Mag. 1997 Sep-Oct; 16(5):74-85. View Abstract
  191. Radiofrequency ablation of intraatrial reentrant tachycardia after surgery for congenital heart disease. Pacing Clin Electrophysiol. 1997 Aug; 20(8 Pt 2):2112-7. View Abstract
  192. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol. 1997 Jul; 8(7):812-7. View Abstract
  193. Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients. Pacing Clin Electrophysiol. 1997 Jun; 20(6):1654-61. View Abstract
  194. Predictors of permanence of successful radiofrequency lesions created with controlled catheter tip temperature. Pacing Clin Electrophysiol. 1997 May; 20(5 Pt 1):1283-91. View Abstract
  195. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol. 1997 Apr; 29(5):1046-53. View Abstract
  196. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997 Mar; 8(3):259-70. View Abstract
  197. Multipolar endocardial mapping of the right heart using a basket catheter: acute and chronic animal studies. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 1):51-9. View Abstract
  198. Low-temperature mapping predicts site of successful ablation while minimizing myocardial damage. Circulation. 1996 Aug 01; 94(3):253-7. View Abstract
  199. Baroreflex gain: characterization using autoregressive moving average analysis. Am J Physiol. 1996 Apr; 270(4 Pt 2):H1240-9. View Abstract
  200. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996 Apr; 27(5):1246-50. View Abstract
  201. Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group. Am J Cardiol. 1996 Mar 15; 77(8):655-8. View Abstract
  202. High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. J Electrocardiol. 1996; 29 Suppl:234-40. View Abstract
  203. Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol. 1995 Dec; 6(12):1129-48. View Abstract
  204. Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Am J Cardiol. 1995 Jun 15; 75(17):1278-81. View Abstract
  205. Respiratory sinus arrhythmia: time domain characterization using autoregressive moving average analysis. Am J Physiol. 1995 Jun; 268(6 Pt 2):H2232-8. View Abstract
  206. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995 May; 18(5 Pt 1):1005-16. View Abstract
  207. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995 Feb 01; 91(3):707-14. View Abstract
  208. Efficacy and safety of radiofrequency ablation in infants and young children < 18 months of age. Am J Cardiol. 1994 Nov 01; 74(9):944-7. View Abstract
  209. Staged pacing therapy for congenital complete heart block in premature infants. Am J Cardiol. 1994 Aug 15; 74(4):412-3. View Abstract
  210. Comparison of intraarterial with continuous noninvasive blood pressure measurement in postoperative pediatric patients. J Clin Monit. 1994 Jan; 10(1):11-20. View Abstract
  211. Blood pressure modulation by central venous pressure and respiration. Buffering effects of the heart rate reflexes. Circulation. 1994 Jan; 89(1):169-79. View Abstract
  212. Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J Am Coll Cardiol. 1993 Jul; 22(1):207-15. View Abstract
  213. Mild hypovolemic stress alters autonomic modulation of heart rate. Hypertension. 1993 Feb; 21(2):236-47. View Abstract
  214. Closure of congenital and acquired intracardiac shunts using transcatheter techniques: a review. Indian Heart J. 1992 May-Jun; 44(3):125-31. View Abstract
  215. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg. 1989 May; 97(5):785-97. View Abstract
  216. The human tumor colony forming assay: review and clinical applications. R I Med J (1976). 1985 Aug; 68(8):361-6. View Abstract

Contact John K. Triedman

Print Profile